Elanco Animal Health Stock Performance
| ELAN Stock | USD 24.08 0.12 0.50% |
Elanco Animal has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.0, which means possible diversification benefits within a given portfolio. Elanco Animal returns are very sensitive to returns on the market. As the market goes up or down, Elanco Animal is expected to follow. Elanco Animal Health right now shows a risk of 2.09%. Please confirm Elanco Animal Health value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to decide if Elanco Animal Health will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Elanco Animal Health are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Elanco Animal may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return (0.50) | Five Day Return (1.11) | Year To Date Return 6.93 | Ten Year Return (33.11) | All Time Return (33.11) |
1 | Reviewing Bioqual Elanco Animal Health | 11/28/2025 |
2 | Elanco Animal Health Assessing Valuation After a Strong Share Price Recovery | 12/16/2025 |
3 | Disposition of 60000 shares by R Hoover of Elanco Animal subject to Rule 16b-3 | 12/19/2025 |
4 | Acquisition by Lawrence Kurzius of 10000 shares of Elanco Animal at 10.9 subject to Rule 16b-3 | 12/23/2025 |
5 | Elanco Valuation Check After Credelio Quattro-CA1 Approval and Growing Wall Street Optimism | 12/24/2025 |
6 | Acquisition by Rajeev Modi of tradable shares of Elanco Animal subject to Rule 16b-3 | 12/26/2025 |
7 | Acquisition by Jeffrey Simmons of 117 shares of Elanco Animal subject to Rule 16b-3 | 01/09/2026 |
8 | Elanco CEO Gaining Market Share Via Major Innovations | 01/12/2026 |
9 | A Look At Elanco Animal Healths Valuation After Befrena Approval And Pet Care Growth Focus | 01/14/2026 |
10 | Acquisition by Kapila Anand of 381 shares of Elanco Animal subject to Rule 16b-3 | 01/20/2026 |
11 | Wall Street Zen Upgrades Elanco Animal Health to Strong-Buy | 01/21/2026 |
12 | Acquisition by Robert VanHimbergen of tradable shares of Elanco Animal subject to Rule 16b-3 | 01/23/2026 |
13 | Elanco Approvals And Clinic Gains Shape Updated Valuation Outlook | 01/27/2026 |
14 | Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health | 01/28/2026 |
| Begin Period Cash Flow | 352 M | |
| Total Cashflows From Investing Activities | 1.2 B |
Elanco Animal Relative Risk vs. Return Landscape
If you would invest 2,285 in Elanco Animal Health on November 3, 2025 and sell it today you would earn a total of 123.00 from holding Elanco Animal Health or generate 5.38% return on investment over 90 days. Elanco Animal Health is currently generating 0.106% in daily expected returns and assumes 2.085% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than Elanco, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Elanco Animal Target Price Odds to finish over Current Price
The tendency of Elanco Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 24.08 | 90 days | 24.08 | about 9.86 |
Based on a normal probability distribution, the odds of Elanco Animal to move above the current price in 90 days from now is about 9.86 (This Elanco Animal Health probability density function shows the probability of Elanco Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Elanco Animal has a beta of 1.0 suggesting Elanco Animal Health market returns are highly reactive to returns on the market. As the market goes up or down, Elanco Animal is expected to follow. Additionally Elanco Animal Health has an alpha of 0.0951, implying that it can generate a 0.0951 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Elanco Animal Price Density |
| Price |
Predictive Modules for Elanco Animal
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Elanco Animal Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Elanco Animal Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Elanco Animal is not an exception. The market had few large corrections towards the Elanco Animal's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Elanco Animal Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Elanco Animal within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 1.07 | |
Ir | Information ratio | 0.05 |
Elanco Animal Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Elanco Animal for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Elanco Animal Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: US Stock Market Today SP 500 Futures Edge Higher As Fed And Shutdown Loom |
Elanco Animal Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Elanco Stock often depends not only on the future outlook of the current and potential Elanco Animal's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Elanco Animal's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 497.3 M | |
| Cash And Short Term Investments | 468 M |
Elanco Animal Fundamentals Growth
Elanco Stock prices reflect investors' perceptions of the future prospects and financial health of Elanco Animal, and Elanco Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elanco Stock performance.
| Return On Equity | 0.0054 | ||||
| Return On Asset | 0.0115 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 15.54 B | ||||
| Shares Outstanding | 496.86 M | ||||
| Price To Earning | 241.75 X | ||||
| Price To Book | 1.78 X | ||||
| Price To Sales | 2.61 X | ||||
| Revenue | 4.44 B | ||||
| Gross Profit | 2.52 B | ||||
| EBITDA | 1.49 B | ||||
| Net Income | 338 M | ||||
| Cash And Equivalents | 463 M | ||||
| Cash Per Share | 0.98 X | ||||
| Total Debt | 4.32 B | ||||
| Debt To Equity | 0.87 % | ||||
| Current Ratio | 1.96 X | ||||
| Book Value Per Share | 13.58 X | ||||
| Cash Flow From Operations | 541 M | ||||
| Earnings Per Share | 0.07 X | ||||
| Market Capitalization | 11.96 B | ||||
| Total Asset | 12.61 B | ||||
| Retained Earnings | (1.95 B) | ||||
| Working Capital | 1.9 B | ||||
| Current Asset | 2.45 B | ||||
| Current Liabilities | 805.47 M | ||||
About Elanco Animal Performance
By examining Elanco Animal's fundamental ratios, stakeholders can obtain critical insights into Elanco Animal's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Elanco Animal is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 204.37 | 182.02 | |
| Return On Tangible Assets | 0.09 | 0.09 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.06 | 0.07 |
Things to note about Elanco Animal Health performance evaluation
Checking the ongoing alerts about Elanco Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elanco Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: US Stock Market Today SP 500 Futures Edge Higher As Fed And Shutdown Loom |
- Analyzing Elanco Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elanco Animal's stock is overvalued or undervalued compared to its peers.
- Examining Elanco Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elanco Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elanco Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elanco Animal's stock. These opinions can provide insight into Elanco Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Pharmaceuticals sector continue expanding? Could Elanco diversify its offerings? Factors like these will boost the valuation of Elanco Animal. Projected growth potential of Elanco fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Elanco Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.167 | Earnings Share 0.07 | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elanco Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elanco Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elanco Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.